 Karin Zemski Berry
Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phospholipids | 9 | 2024 | 223 | 1.750 |
Why?
| | Insulin Resistance | 8 | 2025 | 1208 | 1.300 |
Why?
| | Phosphatidylethanolamines | 5 | 2013 | 77 | 1.220 |
Why?
| | Muscle, Skeletal | 5 | 2025 | 1724 | 1.080 |
Why?
| | Adipose Tissue | 4 | 2025 | 635 | 1.040 |
Why?
| | Ceramides | 4 | 2024 | 118 | 0.990 |
Why?
| | Phosphatidylcholines | 4 | 2024 | 147 | 0.980 |
Why?
| | Sarcolemma | 1 | 2024 | 43 | 0.900 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2017 | 144 | 0.890 |
Why?
| | Lipid Metabolism | 2 | 2025 | 518 | 0.790 |
Why?
| | Lipids | 6 | 2022 | 672 | 0.790 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 7 | 2016 | 180 | 0.660 |
Why?
| | Weight Loss | 1 | 2025 | 787 | 0.660 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2024 | 2531 | 0.630 |
Why?
| | Obesity | 9 | 2025 | 2992 | 0.600 |
Why?
| | Docosahexaenoic Acids | 5 | 2024 | 84 | 0.600 |
Why?
| | Arachidonate 5-Lipoxygenase | 2 | 2016 | 43 | 0.590 |
Why?
| | Tandem Mass Spectrometry | 6 | 2024 | 532 | 0.580 |
Why?
| | Plasmalogens | 3 | 2013 | 6 | 0.570 |
Why?
| | Isotope Labeling | 2 | 2009 | 81 | 0.540 |
Why?
| | Ozone | 1 | 2016 | 132 | 0.460 |
Why?
| | Placenta | 5 | 2024 | 750 | 0.460 |
Why?
| | Exercise | 1 | 2025 | 2057 | 0.430 |
Why?
| | Optic Nerve | 1 | 2013 | 64 | 0.420 |
Why?
| | Macrophages, Alveolar | 1 | 2016 | 391 | 0.410 |
Why?
| | para-Aminobenzoates | 2 | 2010 | 7 | 0.400 |
Why?
| | Computational Biology | 1 | 2017 | 644 | 0.380 |
Why?
| | Oxidation-Reduction | 4 | 2024 | 1060 | 0.380 |
Why?
| | Retina | 1 | 2013 | 298 | 0.360 |
Why?
| | Fetal Blood | 2 | 2024 | 327 | 0.350 |
Why?
| | Acrolein | 1 | 2007 | 23 | 0.280 |
Why?
| | Imaging, Three-Dimensional | 1 | 2011 | 580 | 0.270 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2024 | 218 | 0.250 |
Why?
| | Triglycerides | 5 | 2022 | 524 | 0.240 |
Why?
| | Glycerylphosphorylcholine | 1 | 2005 | 6 | 0.230 |
Why?
| | Paracrine Communication | 1 | 2025 | 65 | 0.230 |
Why?
| | Methane | 1 | 2005 | 49 | 0.220 |
Why?
| | Free Radicals | 1 | 2005 | 110 | 0.220 |
Why?
| | Diglycerides | 1 | 2024 | 61 | 0.220 |
Why?
| | Lung | 1 | 2017 | 4060 | 0.210 |
Why?
| | Fatty Acids, Unsaturated | 3 | 2016 | 99 | 0.210 |
Why?
| | Symporters | 1 | 2023 | 66 | 0.210 |
Why?
| | Liposomes | 4 | 2010 | 223 | 0.210 |
Why?
| | Hyperinsulinism | 1 | 2024 | 121 | 0.200 |
Why?
| | Chromatography, Liquid | 3 | 2023 | 433 | 0.200 |
Why?
| | Mitochondrial Diseases | 1 | 2023 | 91 | 0.200 |
Why?
| | Pancreas | 1 | 2025 | 329 | 0.200 |
Why?
| | Oxygen | 2 | 2022 | 931 | 0.200 |
Why?
| | Glycerol | 1 | 2022 | 94 | 0.190 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2023 | 140 | 0.190 |
Why?
| | Animals | 13 | 2024 | 36940 | 0.190 |
Why?
| | Humans | 25 | 2025 | 137585 | 0.190 |
Why?
| | Intra-Abdominal Fat | 1 | 2022 | 91 | 0.190 |
Why?
| | Overnutrition | 1 | 2022 | 30 | 0.190 |
Why?
| | Chromatography, High Pressure Liquid | 3 | 2010 | 597 | 0.180 |
Why?
| | Mass Spectrometry | 1 | 2005 | 739 | 0.180 |
Why?
| | Dietary Supplements | 2 | 2024 | 561 | 0.180 |
Why?
| | Female | 14 | 2025 | 73304 | 0.170 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2016 | 220 | 0.170 |
Why?
| | Immunity | 1 | 2020 | 143 | 0.160 |
Why?
| | Mice | 10 | 2024 | 17787 | 0.160 |
Why?
| | Middle Aged | 5 | 2025 | 33479 | 0.150 |
Why?
| | Heart Diseases | 1 | 2022 | 346 | 0.150 |
Why?
| | Transcription, Genetic | 1 | 2025 | 1457 | 0.150 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5472 | 0.150 |
Why?
| | Rats | 2 | 2024 | 5647 | 0.150 |
Why?
| | Cell Cycle Proteins | 2 | 2016 | 617 | 0.150 |
Why?
| | Lysophospholipids | 2 | 2008 | 80 | 0.140 |
Why?
| | Insulin | 2 | 2025 | 2409 | 0.130 |
Why?
| | Arachidonic Acid | 2 | 2009 | 120 | 0.130 |
Why?
| | Fetal Growth Retardation | 1 | 2022 | 565 | 0.130 |
Why?
| | Adult | 5 | 2025 | 37929 | 0.130 |
Why?
| | Pregnancy | 6 | 2024 | 6763 | 0.130 |
Why?
| | Male | 8 | 2025 | 67762 | 0.120 |
Why?
| | Neutrophils | 3 | 2007 | 1238 | 0.120 |
Why?
| | Biological Transport | 1 | 2017 | 418 | 0.120 |
Why?
| | Body Mass Index | 1 | 2024 | 2389 | 0.120 |
Why?
| | Phenotype | 1 | 2024 | 3196 | 0.120 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2022 | 605 | 0.120 |
Why?
| | Molecular Structure | 2 | 2007 | 489 | 0.110 |
Why?
| | Sulfoglycosphingolipids | 1 | 2013 | 3 | 0.110 |
Why?
| | Photoreceptor Cells, Vertebrate | 1 | 2013 | 26 | 0.110 |
Why?
| | Cell Line | 2 | 2010 | 2847 | 0.110 |
Why?
| | Subcutaneous Fat | 2 | 2025 | 81 | 0.100 |
Why?
| | Lysophosphatidylcholines | 2 | 2024 | 22 | 0.100 |
Why?
| | Colitis | 1 | 2016 | 266 | 0.100 |
Why?
| | Retinal Pigment Epithelium | 1 | 2013 | 77 | 0.100 |
Why?
| | Prostatic Neoplasms | 1 | 2020 | 1043 | 0.100 |
Why?
| | Mice, Inbred C57BL | 3 | 2023 | 5757 | 0.100 |
Why?
| | Interferon-gamma | 1 | 2016 | 789 | 0.100 |
Why?
| | Carnitine | 2 | 2024 | 84 | 0.100 |
Why?
| | Culture Media, Conditioned | 2 | 2022 | 110 | 0.100 |
Why?
| | Sphingolipids | 2 | 2023 | 77 | 0.100 |
Why?
| | Fatty Acids | 2 | 2024 | 443 | 0.090 |
Why?
| | Organ Specificity | 1 | 2011 | 305 | 0.080 |
Why?
| | 4-Aminobenzoic Acid | 1 | 2009 | 7 | 0.080 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 2111 | 0.080 |
Why?
| | Arachidonate 12-Lipoxygenase | 1 | 2009 | 18 | 0.080 |
Why?
| | Eicosanoids | 2 | 2009 | 62 | 0.080 |
Why?
| | Arachidonate 15-Lipoxygenase | 1 | 2009 | 23 | 0.080 |
Why?
| | Apolipoproteins E | 1 | 2009 | 83 | 0.080 |
Why?
| | Macrophages, Peritoneal | 1 | 2009 | 94 | 0.080 |
Why?
| | Monoglycerides | 1 | 2008 | 2 | 0.080 |
Why?
| | Fetus | 2 | 2024 | 806 | 0.080 |
Why?
| | Peritonitis | 1 | 2009 | 84 | 0.070 |
Why?
| | HL-60 Cells | 1 | 2007 | 34 | 0.070 |
Why?
| | Secretory Vesicles | 1 | 2007 | 23 | 0.070 |
Why?
| | Neutrophil Activation | 1 | 2007 | 80 | 0.070 |
Why?
| | Calcimycin | 1 | 2005 | 49 | 0.060 |
Why?
| | Ionophores | 1 | 2005 | 24 | 0.060 |
Why?
| | Calcium Signaling | 1 | 2007 | 249 | 0.060 |
Why?
| | Hydrocarbons | 1 | 2005 | 31 | 0.060 |
Why?
| | Atherosclerosis | 1 | 2009 | 415 | 0.060 |
Why?
| | Models, Molecular | 1 | 2010 | 1570 | 0.060 |
Why?
| | Lipid Peroxidation | 1 | 2005 | 153 | 0.060 |
Why?
| | Membrane Lipids | 1 | 2005 | 91 | 0.050 |
Why?
| | Ubiquinone | 1 | 2023 | 29 | 0.050 |
Why?
| | Aldehydes | 1 | 2005 | 145 | 0.050 |
Why?
| | Glucose Clamp Technique | 1 | 2024 | 195 | 0.050 |
Why?
| | Electron Transport | 1 | 2023 | 115 | 0.050 |
Why?
| | Choline | 1 | 2024 | 127 | 0.050 |
Why?
| | Models, Chemical | 1 | 2005 | 263 | 0.050 |
Why?
| | Isophane Insulin, Human | 1 | 2022 | 5 | 0.050 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2022 | 22 | 0.050 |
Why?
| | Signal Transduction | 1 | 2016 | 5079 | 0.050 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2024 | 176 | 0.050 |
Why?
| | Membrane Transport Proteins | 1 | 2023 | 162 | 0.050 |
Why?
| | Acyltransferases | 1 | 2022 | 57 | 0.050 |
Why?
| | Arachidonic Acids | 1 | 2022 | 62 | 0.050 |
Why?
| | Adipokines | 1 | 2022 | 49 | 0.050 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 86 | 0.050 |
Why?
| | Adult Children | 1 | 2022 | 24 | 0.050 |
Why?
| | Rheology | 1 | 2022 | 92 | 0.050 |
Why?
| | Ultraviolet Rays | 1 | 2005 | 396 | 0.050 |
Why?
| | Dinoprostone | 1 | 2022 | 191 | 0.050 |
Why?
| | Vasodilation | 1 | 2025 | 499 | 0.050 |
Why?
| | Fetal Heart | 1 | 2022 | 55 | 0.050 |
Why?
| | Interleukin-13 | 1 | 2022 | 149 | 0.050 |
Why?
| | Phosphates | 1 | 2022 | 182 | 0.050 |
Why?
| | Aged, 80 and over | 1 | 2013 | 7635 | 0.050 |
Why?
| | Interleukin-8 | 1 | 2022 | 268 | 0.050 |
Why?
| | Acute Disease | 1 | 2024 | 1007 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2023 | 622 | 0.040 |
Why?
| | Cell Membrane | 1 | 2005 | 738 | 0.040 |
Why?
| | Ranolazine | 1 | 2020 | 25 | 0.040 |
Why?
| | PPAR gamma | 1 | 2022 | 182 | 0.040 |
Why?
| | Cardiomegaly | 1 | 2022 | 175 | 0.040 |
Why?
| | Macrophages | 1 | 2008 | 1547 | 0.040 |
Why?
| | Athletes | 1 | 2024 | 423 | 0.040 |
Why?
| | Ultrasonography, Prenatal | 1 | 2022 | 285 | 0.040 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2020 | 224 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2023 | 2833 | 0.040 |
Why?
| | Tumor Burden | 1 | 2020 | 309 | 0.040 |
Why?
| | Cell Line, Tumor | 1 | 2007 | 3412 | 0.040 |
Why?
| | Pregnancy Complications | 1 | 2024 | 527 | 0.040 |
Why?
| | Birth Weight | 1 | 2022 | 516 | 0.040 |
Why?
| | Islets of Langerhans | 1 | 2025 | 803 | 0.040 |
Why?
| | Erythrocytes | 1 | 2024 | 700 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2022 | 778 | 0.040 |
Why?
| | Molecular Targeted Therapy | 1 | 2020 | 411 | 0.030 |
Why?
| | Young Adult | 2 | 2024 | 13209 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2020 | 483 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1242 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 1020 | 0.030 |
Why?
| | Dextran Sulfate | 1 | 2016 | 83 | 0.030 |
Why?
| | Ions | 1 | 2016 | 70 | 0.030 |
Why?
| | Mice, Knockout | 2 | 2016 | 3015 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2020 | 900 | 0.030 |
Why?
| | Aged | 1 | 2013 | 23961 | 0.030 |
Why?
| | Time Factors | 1 | 2005 | 6828 | 0.030 |
Why?
| | Biomarkers, Tumor | 1 | 2020 | 1276 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2016 | 1178 | 0.020 |
Why?
| | Brain | 1 | 2023 | 2668 | 0.020 |
Why?
| | Cells, Cultured | 2 | 2008 | 4193 | 0.020 |
Why?
| | Peritoneal Lavage | 1 | 2009 | 8 | 0.020 |
Why?
| | Phosphatidylglycerols | 1 | 2008 | 24 | 0.020 |
Why?
| | Organ Size | 1 | 2009 | 477 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2009 | 283 | 0.020 |
Why?
| | GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2007 | 17 | 0.020 |
Why?
| | Type C Phospholipases | 1 | 2007 | 74 | 0.020 |
Why?
| | Spleen | 1 | 2009 | 514 | 0.020 |
Why?
| | Aorta | 1 | 2009 | 417 | 0.020 |
Why?
| | Cholesterol | 1 | 2008 | 410 | 0.020 |
Why?
| | Thromboxanes | 1 | 2005 | 17 | 0.020 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2005 | 8 | 0.020 |
Why?
| | Isoprostanes | 1 | 2005 | 15 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2016 | 4295 | 0.020 |
Why?
| | Leukotrienes | 1 | 2005 | 37 | 0.020 |
Why?
| | Prostaglandins | 1 | 2005 | 97 | 0.010 |
Why?
|
|
Zemski Berry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|